c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.

The transmembrane neural cell adhesion receptor L1 is a Wnt/β-catenin target gene expressed in many tumor types. In human colorectal cancer, L1 localizes preferentially to the invasive front of tumors and when overexpressed in colorectal cancer cells, it facilitates their metastasis to the liver. In this study, we investigated genes that are regulated in human colorectal cancer and by the L1-NF-κB pathway that has been implicated in liver metastasis. c-Kit was the most highly suppressed gene in both colorectal cancer tissue and the L1-NF-κB pathway. c-Kit suppression that resulted from L1-mediated signaling relied upon NF-κB, which directly inhibited the transcription of SP1, a major activator of the c-Kit gene promoter. Reconstituting c-Kit expression in L1-transfected cells blocked the biological effects conferred by L1 overexpression in driving motility and liver metastasis. We found that c-Kit expression in colorectal cancer cells is associated with a more pronounced epithelial morphology, along with increased expression of E-cadherin and decreased expression of Slug. Although c-Kit overexpression inhibited the motility and metastasis of L1-expressing colorectal cancer cells, it enhanced colorectal cancer cell proliferation and tumorigenesis, arguing that separate pathways mediate tumorigenicity and metastasis by c-Kit. Our findings provide insights into how colorectal cancer metastasizes to the liver, the most common site of dissemination in this cancer.

[1]  M. Mareel,et al.  The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. , 2002, Cancer research.

[2]  B. Vanderhyden,et al.  Lack of expression of c‐KIT in ovarian cancers is associated with poor prognosis , 2000, International journal of cancer.

[3]  M. Toyota,et al.  Expression and identification of aberrant c-kit transcripts in human cancer cells. , 1997, Cancer letters.

[4]  A. Baldwin,et al.  Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. , 2006, Oncogene.

[5]  Rainer Breitling,et al.  A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments , 2008, Bioinform..

[6]  M. Caligiuri,et al.  Sp1/NF κ B/HDAC/ miR-29b Regulatory Network in KIT-driven Myeloid Leukemia , 2010 .

[7]  Eytan Domany,et al.  Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes , 2010, BMC Bioinformatics.

[8]  A. Ben-Ze'ev,et al.  Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells , 2010, Journal of Cell Science.

[9]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[10]  P. Einat,et al.  Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. , 2002, Genes & development.

[11]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[12]  T. Hunter,et al.  Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility , 2000, Nature Genetics.

[13]  Ramon Kranaster,et al.  A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro , 2011, Nucleic acids research.

[14]  F. Lordick,et al.  Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas , 2010, Langenbeck's Archives of Surgery.

[15]  V. Sondak,et al.  c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. , 2009, Histology and histopathology.

[16]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[17]  Terry M. Therneau,et al.  Faster cyclic loess: normalizing RNA arrays via linear models , 2004, Bioinform..

[18]  M. Tainsky,et al.  Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis , 1998, The EMBO journal.

[19]  S. Lev,et al.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Yeatman,et al.  Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. , 2002, Clinical colorectal cancer.

[21]  A. Baldwin,et al.  Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.

[22]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[23]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[24]  A. Ben-Ze'ev,et al.  Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression , 2013, Oncogene.

[25]  U. Rodeck,et al.  Growth stimulation of colorectal carcinoma cells via the c‐kit receptor is inhibited by TGF‐β1 , 1997 .

[26]  S. Tsutsui,et al.  A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer , 2006, British Journal of Cancer.

[27]  S. Quake,et al.  Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. , 2012, Gastroenterology.

[28]  D. Nowak,et al.  Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration. , 2011, European journal of pharmacology.

[29]  M. Karin Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[30]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[31]  D. Radisky,et al.  MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits , 2012, Nature Cell Biology.

[32]  P. Polakis The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[33]  H. Clevers Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[34]  Johan Lennartsson,et al.  Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.

[35]  C. Sette,et al.  Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients , 2004, International Journal of Colorectal Disease.

[36]  D. Notterman,et al.  Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. , 2007, Cancer research.

[37]  M. Caligiuri,et al.  Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. , 2010, Cancer cell.

[38]  C. Sonnenschein,et al.  Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats , 2008, Cancer Cell International.

[39]  U. Rodeck,et al.  Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. , 2001, Cancer research.

[40]  F. Da Settimo,et al.  Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview. , 2011, Current medicinal chemistry.

[41]  C. Unger,et al.  c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis , 2010, Pathology & Oncology Research.

[42]  N. S. Yee,et al.  Differential roles of PI3‐kinase and Kit tyrosine 821 in Kit receptor‐mediated proliferation, survival and cell adhesion in mast cells. , 1995, The EMBO journal.

[43]  M. Karin Nuclear factor-κB in cancer development and progression , 2006, Nature.

[44]  I. Roninson,et al.  Regulation of Sp1 by cell cycle related proteins , 2008, Cell cycle.

[45]  H. Kanzaki,et al.  The expression of c-kit protein in human adult and fetal tissues. , 1993, Human Reproduction.

[46]  Eytan Domany,et al.  Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.